Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $77.82 USD
Change Today -0.59 / -0.75%
Volume 3.0M
MDT On Other Exchanges
Symbol
Exchange
New York
Mexico
Frankfurt
As of 8:04 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Transactions by MEDTRONIC PLC (MDT) in the last 6 months

Announced 04/20/15
175.00M for Spinal Modulation, Inc.
Merger/Acquisition

St. Jude Medical Inc. (NYSE:STJ) agreed to acquire remaining stake in Spinal Modulation, Inc. from De Novo Ventures, InCube Ventures, LLC, Johnson & Johnson Innovation - JJDC, Inc., Kleiner Perkins Caufield & Byers, Raffles Venture Partners, Medtronic plc (NYSE:MDT), MedVenture Associates V, L.P., managed by MedVenture Associates, The Angels' Forum LLC, The Halo Funds and others for approximately $180 million on April 20, 2015. St. Jude Medical will also make additional ...
Read More


MDT's price was unchanged after the transaction was announced on 04/20/15.
Investor / Buyer
St. Jude Medical Inc.
Creditor / Lender
De Novo Ventures
DFJ ePlanet Ventures, L.P.
Draper Fisher Jurvetson
ePlanet Capital
InCube Ventures, LLC
Johnson & Johnson Innovation - JJDC, Inc.
Kleiner Perkins Caufield & Byers
Medtronic plc
MedVenture Associates
MedVenture Associates V, L.P.
Raffles Venture Partners
The Angels' Forum LLC
The Halo Funds
 
Announced 04/6/15
2.00M for DreaMed Diabetes, Ltd.
Private Placement

DreaMed Diabete announced that it has received $2 million in an equity round of funding from new investor Medtronic plc on April 6, 2015.


MDT's price was unchanged after the transaction was announced on 04/6/15.
Investor / Buyer
Medtronic plc
 
Announced 04/2/15
Diabeter B.V.
Merger/Acquisition

Medtronic plc (NYSE:MDT) acquired Diabeter on April 2, 2015. Amanda Sheldon acted as the public relation advisor and Jeff Warren acted as the investor relation advisor in this transaction.


MDT's price was unchanged after the transaction was announced on 04/2/15.
Investor / Buyer
Medtronic plc
 
Announced 03/26/15
Sophono, Inc
Merger/Acquisition

Medtronic plc (NYSE:MDT) acquired Sophono, Inc. on March 26, 2015. The transaction enables Medtronic's Ear Nose and Throat business to continue its focus on novel therapies and innovative technology solutions and supports Medtronic's therapy innovation strategy. Medtronic will include revenue from the Sophono product line as part of the Surgical Technologies division within the Restorative Therapies Group segment. The transaction is expected to meet Medtronic's long-term ...
Read More


MDT's price was unchanged after the transaction was announced on 03/26/15.
Investor / Buyer
Medtronic plc
Creditor / Lender
Boulder BioMed, Inc.
Colorado Institute for Drug, Device & Diagnostic Development
Wexford Capital LLC
Wexford Capital, LLC, Private Equity Arm
 
Announced 03/18/15
44.00M for Semma Therapeutics, Inc.
Private Placement

Semma Therapeutics announced that it has received $44,000,000 in its series A round of funding led by new investor, MPM Capital on March 18, 2015. The transaction included participation from new investors, Arch Venture Partners, L.P., Fidelity Biosciences, and Medtronic plc. The company issued series A preferred stock in the transaction. As a part of the transaction, Robert Millman, Todd Foley, and Jim Scopa of MPM Capital, Steven Knight of Fidelity Biosciences joined ...
Read More


MDT's price was unchanged after the transaction was announced on 03/18/15.
Investor / Buyer
Arch Venture Partners, L.P.
Fidelity Biosciences
Medtronic plc
MPM Capital
 
Announced 03/17/15
17.00M for Glooko, Inc.
Private Placement

Glooko, Inc. announced that it has received $16.5 million in its series B round of funding co-led by new investor, Canaan Partners and Medtronic plc on March 17, 2015. The transaction included participation from existing investors, Samsung Venture Investment Corporation and The Social+Capital Partnership. The company has raised $27.5 million in funding till date. As part of the round, Wende Huttonof Canaan Partners joined the company's board of directors.


MDT's price was unchanged after the transaction was announced on 03/17/15.
Investor / Buyer
Canaan Partners
Medtronic plc
Samsung Venture Investment Corporation
The Social+Capital Partnership
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDT:US $77.82 USD -0.59

MDT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $65.48 USD -0.17
Actavis plc $301.35 USD +0.13
Amgen Inc $163.58 USD -0.26
Bristol-Myers Squibb Co $68.30 USD -0.59
GlaxoSmithKline PLC 1,465 GBp +14.00
View Industry Companies
 

Industry Analysis

MDT

Industry Average

Valuation MDT Industry Range
Price/Earnings 25.1x
Price/Sales 4.4x
Price/Book 3.8x
Price/Cash Flow 32.2x
TEV/Sales 3.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDTRONIC PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.